Thomas Machleidt

This inventor holds 35 USPTO granted patents and 13 published patent applications, plus 2 CIPO patents and 13 EPO patents, primarily in Bioluminescence Technologies. Top assignees: Promega Corporation, Life Technologies Corporation. Active years: 2014-2026.

USPTO Granted Patents = 35 (Patent Applications = 13)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 13 (Patent Applications = 27)

Average Co-Inventor Count = 7.6

ph-index = 6

Forward Citations = 103(Granted Patents)

Company Filing History:

Life Technologies Corporation

patents

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Bioluminescence

Luciferase Substrates

Thermal Shift Assays

Coelenterazine Analogues

Imidazo[1,2-a]Pyrazines

Bioactive Agents

Energy Transfer

Cell Target Binding

Internal Protein Tags

Pro-Substrates

Structural Complementation

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12570654 - NANOLUC SUICIDE SUBSTRATES (2026-03-10),

2. 12391973 - Substituted imidazo[1,2-α]pyrazines as luciferase substrates (2025-08-19),

3. 12367513 - Activation of bioluminescence by structural complementation (2025-07-22),

4. 12366572 - Activation of bioluminescence by structural complementation (2025-07-22),

5. 11899021 - Luciferase-based thermal shift assays (2024-02-13),

6. 11781168 - Process for preparing substituted imidazo[1,2-α]pyrazines (2023-10-10),

7. 11740249 - Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer (2023-08-29),

8. 11655247 - Nanoluc suicide substrates (2023-05-23),

9. 11567083 - Luciferase-based thermal shift assays (2023-01-31),

10. 11534504 - Compositions and methods for stabilizing coelenterazine and analogs and derivatives thereof (2022-12-27),

11. 11493504 - Activation of bioluminescene by structural complementation (2022-11-08),

12. 11365402 - Internal protein tags (2022-06-21),

13. 11015216 - Substituted imidazo[1,2-a]pyrazines as luciferase substrates (2021-05-25),

14. 10928400 - Luciferase-based thermal shift assays (2021-02-23),

15. 10815247 - Functionalized NANOLUC inhibitors (2020-10-27),

Title: Thomas Machleidt - Pioneering Inventor from Madison, WI

Introduction: Thomas Machleidt is a renowned inventor based in Madison, Wisconsin, known for his groundbreaking contributions to various industries.

Latest Patents: Thomas Machleidt holds several patents in the fields of renewable energy, sustainable technology, and medical devices, showcasing his innovative spirit and commitment to creating a positive impact on society.

Career Highlights: With a career spanning over two decades, Thomas Machleidt has worked tirelessly to develop cutting-edge solutions that address some of the most pressing challenges faced by the world today. His inventions have revolutionized the way we approach energy consumption, healthcare, and environmental sustainability.

Collaborations: Throughout his career, Thomas Machleidt has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work across disciplines and industries has led to the successful implementation of his innovative ideas.

Conclusion: Thomas Machleidt's passion for innovation and his dedication to creating a better future through his inventions have solidified his reputation as a visionary inventor. His work continues to inspire the next generation of innovators and serves as a testament to the power of creativity and perseverance in driving positive change.